In a mouse liver cancer model, fibroblast activation protein (FAP)–STAT3–CCL2 signaling in cancer-associated fibroblasts (CAFs) promoted tumor growth by enhancing MDSC mobilization and FAP-mediated tumor promotion, and MDSC mobilization in CAF was abolished in CCR2-deficient mice [57]. This evidence concerns the gene CCR2 and cancer.